A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
Shared connections to type 1 diabetes (T1D) brought together more than 600 people at the recent JDRF Type 1 Diabetes Research Summit held in Washington, D.C. Hosted by the JDRF Capitol Chapter, this one-day event was filled with informative, easy-to-understand presentations by top T1D researchers. Attendees had the opportunity to hear directly from these top […]
For people living with type 1 diabetes (T1D), establishing insulin independence by implanting insulin-producing beta cells into the body would be life changing. But a challenge to this potential therapy lies in the body’s immune system, which recognizes the implanted beta cells as foreign entities or invaders and subsequently attacks them. Furthermore, the implanted beta […]
The collaborative partnership of JDRF and The Leona M. and Harry B. Helmsley Charitable Trust has awarded a new grant in one of the most exciting and promising areas of type 1 diabetes (T1D) research. The $4.6-million grant, distributed over three years, will fund the beta cell encapsulation research of Camillo Ricordi, M.D., scientific director […]
by Thania Benios For people with type 1 diabetes (T1D) awaiting an islet transplant, a single phone call could change their life. The waiting list for these transplants stretches on, and far too often only serendipity propels a patient to the front of the line. These transplanted islets hold the promise of supplying a patient […]
On March 22–23, 2011, JDRF brought together more than 40 corporate and academic experts on beta cell encapsulation in order to discuss the most recent progress, and to identify critical gaps, in the field. Recommendations from the workshop will guide JDRF’s next wave of research efforts to close these gaps and move the field forward. […]
On August 3, JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust, announced the award of a $4.6 million grant to the laboratory of Camillo Ricordi, M.D., of the Diabetes Research Institute at the University of Miami. The three-year grant will fund research in the area of beta cell encapsulation, a […]
The study provides proof-of-concept that cells that develop into insulin-producing cells can survive, proliferate, and mature in an encapsulation device to the point where they can correct diabetes.